PRA has opened a second office in China as part of its continued expansion in China and the Asia Pacific region. PRA’s new facility, located in the central business district of Beijing, will expand the local project teams’ ability to meet growing demand for clinical drug development programs.   “As the demand for clinical sites in Asia increase, we continually strive to strengthen our existing operations in China and the Asia Pacific region,” said Helen Neal, regional dir...